1. Forty-eight devices manufactured between July 13, 2013, and August 8, 2017, were recalled nationwide.
2. The devices are intended to pace slow heart rhythms and stop dangerously fast heart rhythms through pacing or electrical shock. A manufacturing defect may prevent the recalled products from providing necessary electrical shocks to pace or revive patients in cardiac arrest.
3. Medtronic issued an urgent medical device recall notice in January, asking patients who were implanted with an affected device to consider prophylactic device replacement. The company will offer a supplemental device warranty for recalled devices.
4. A complete list of serial numbers for affected devices is available on the FDA recall notice.
More articles on supply chain:
Boston Scientific closes $1B public offering — 3 insights
Market analysts think Allergan needs to strike a deal as Botox biosimilar announced
Failed osteoarthritis drug could reduce opioid dependence: 6 key insights
